Enzo Biochem's Clinical Labs Subsidiary Launches Drive-Through Facility to Provide COVID-19 Testing on Long Island

Author's Avatar
Mar 24, 2020
Article's Main Image

Enzo Biochem, Inc. (NYSE:ENZ, Financial), a leading biotechnology and diagnostic company, today announced its wholly owned subsidiary, Enzo Clinical Labs, Inc., has expanded its screening services for COVID-19. Following the company’s March 6, 2020 announcement regarding the initiation of accepting specimens for novel Coronavirus (COVID-19) testing, Enzo is now directly collecting specimens at a drive-through facility by appointment in Enzo’s laboratory complex in Farmingdale, New York. This facility has been set up with support from local and state officials.